Skip to main content

Table 2 Comparison at final evaluation between non-switchers and switchers

From: Factors associated with ASDAS remission in a long-term study of ankylosing spondylitis patients under tumor necrosis factor inhibitors

 

Non-switchers (n = 42)

Switchers (n = 36)

P

BASDAI

1.7 ± 1.6

2.6 ± 2.0

0.041*

BASFI

2.8 ± 2.7

4.2 ± 3.0

0.034*

BASMI

2.9 ± 2.2

3.2 ± 2.1

0.635

ASQoL

3.5 (1.0, 8.0)

6.0 (1.5, 10.5)

0.057

CRP, mg/l

2.8 (1.3, 5.0)

4.0 (1.7, 8.6)

0.148

ESR, mm/hr

4.0 (2.0, 8.0)

5.0 (2.0, 15.5)

0.363

ASDAS – CRP

1.5 ± 0.7

2.0 ± 1.0

0.012*

Last anti-TNF treatment duration, weeks

206.6 (96.9, 287.9)

171.9 (101.6, 210.3)

0.146

  1. Values are expressed as mean (SD) and median (quartile). ASDAS Ankylosing Spondylitis Disease Activity Score, ASQoL Ankylosing Spondylitis Quality of Life, BASDAI Bath Ankylosing Spondylitis Disease Activity Index, BASFI Bath Ankylosing Spondylitis Functional Index, BASMI Bath Ankylosing Spondylitis Metrology Index, CRP C Reactive Protein, ESR Erythrocyte Sedimentation Rate, * P < 0.05
Back to article page

Advances in Rheumatology

ISSN: 2523-3106